![Helen Jenkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Helen Jenkins formerly worked at Lengo Therapeutics, Inc., as Chief Executive Officer, Valentis, Inc., as Director-Product Development & Regulatory Affairs, Genentech, Inc., as Principal, Glycomed, Inc., as Principal, Saegis Pharmaceuticals, Inc., as Senior Vice President-Development Operations from 2000 to 2007, Tobira Therapeutics, Inc., as Senior Vice President-Program Leadership from 2011 to 2014, Nuon Therapeutics, Inc., as Chief Operating Officer from 2007 to 2011, and Tobira Therapeutics, Inc., as Chief Operating Officer.
Ms. Jenkins received her graduate degree from San Francisco State University and undergraduate degree from California Polytechnic State University (San Luis Obispo).
Anciens postes connus de Helen Jenkins
| Sociétés | Poste | Fin |
|---|---|---|
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Directeur des opérations | 01/01/2011 |
Saegis Pharmaceuticals, Inc.
 Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapeutics | Directeur des opérations | 01/01/2007 |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Directeur Général | - |
| TOBIRA THERAPEUTICS INC | Directeur des opérations | - |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Directeur des opérations | - |
Formation de Helen Jenkins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Glycomed, Inc.
 Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals based on complex carbohydrates | Health Technology |
Valentis, Inc.
 Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saegis Pharmaceuticals, Inc.
Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapeutics | Health Technology |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Health Technology |
Choisissez Zonebourse 
